Literature DB >> 16779869

Determination of paclitaxel in human plasma following the administration of Genaxol or Genetaxyl by liquid chromatography/tandem mass spectrometry.

Erin R Gardner1, Chi-Ting Liau, Zyting E Chu, William D Figg, Alex Sparreboom.   

Abstract

A sensitive and specific assay for paclitaxel in plasma has been developed to overcome limitations in previously published assays, using liquid chromatography with tandem mass spectrometric detection. Plasma samples (100 microL) were subjected to liquid-liquid extraction with 1-chlorobutane/acetonitrile (4:1, v/v), with [(2)H(5)]paclitaxel employed as the internal standard. Chromatography was carried out with a Waters SymmetryShield C8 column (50 x 2.1 mm, 3.5 microm). The total run time, including equilibration, was 8 min, using a gradient of acetonitrile and 10 mM ammonium formate, pH 4.0. The assay is accurate and precise over the range of 2-2500 ng/mL and has been successfully applied to study the clinical pharmacokinetics of two formulations of paclitaxel, Genaxol and Genetaxyl, given orally and intravenously. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779869     DOI: 10.1002/rcm.2577

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  5 in total

1.  Highly selective and sensitive assay for paclitaxel accumulation by tumor cells based on selective solid phase extraction and micro-flow liquid chromatography coupled to mass spectrometry.

Authors:  Julio R Gaspar; Jun Qu; Ninfa L Straubinger; Robert M Straubinger
Journal:  Analyst       Date:  2008-10-03       Impact factor: 4.616

2.  Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients.

Authors:  Zyting Chu; Jen-Shi Chen; Chi-Ting Liau; Hung-Ming Wang; Yung-Chang Lin; Muh-Hwa Yang; Po-Min Chen; Erin R Gardner; William D Figg; Alex Sparreboom
Journal:  Anticancer Drugs       Date:  2008-03       Impact factor: 2.248

3.  Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment.

Authors:  Erin R Gardner; William Dahut; William D Figg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-28       Impact factor: 3.205

4.  Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.

Authors:  Missak Haigentz; Page Moore; Milan Bimali; Timothy Cooley; Joseph Sparano; Michelle Rudek; Lee Ratner; David Henry; Juan Ramos; John Deeken; Paul Rubinstein; Elizabeth Chiao
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837

5.  A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.

Authors:  Bianca Posocco; Mauro Buzzo; Andrea Follegot; Luciana Giodini; Roberto Sorio; Elena Marangon; Giuseppe Toffoli
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.